340 related articles for article (PubMed ID: 30087057)
1. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
2. SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.
de Veij Mestdagh PD; Jonker MCJ; Vogel WV; Schreuder WH; Donswijk ML; Klop WMC; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2135-2144. PubMed ID: 29955968
[TBL] [Abstract][Full Text] [Related]
3. SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach.
de Veij Mestdagh PD; Walraven I; Vogel WV; Schreuder WH; van Werkhoven E; Carbaat C; Donswijk ML; van den Brekel MWM; Al-Mamgani A
Radiother Oncol; 2020 Jun; 147():56-63. PubMed ID: 32240908
[TBL] [Abstract][Full Text] [Related]
4. Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.
de Veij Mestdagh PD; Schreuder WH; Vogel WV; Donswijk ML; van Werkhoven E; van der Wal JE; Dirven R; Karakullukcu B; Sonke JJ; van den Brekel MWM; Marijnen CAM; Al-Mamgani A
BMC Cancer; 2019 Nov; 19(1):1110. PubMed ID: 31727019
[TBL] [Abstract][Full Text] [Related]
5. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
7. Level II lymph nodes and radiation-induced xerostomia.
Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
[TBL] [Abstract][Full Text] [Related]
8. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study.
Longton E; Lawson G; Bihin B; Mathieu I; Hanin FX; Deheneffe S; Vander Borght T; Laloux M; Daisne JF
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):652-661. PubMed ID: 32294522
[TBL] [Abstract][Full Text] [Related]
9. The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy.
Bitz HC; Sachpazidis I; Zou J; Schnell D; Baltas D; Grosu AL; Nicolay NH; Rühle A
Radiat Oncol; 2024 Apr; 19(1):53. PubMed ID: 38689338
[TBL] [Abstract][Full Text] [Related]
10. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
[No Abstract] [Full Text] [Related]
11. Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift.
Al-Mamgani A; Verheij M; van den Brekel MWM
Eur J Cancer; 2017 Sep; 82():1-5. PubMed ID: 28633075
[TBL] [Abstract][Full Text] [Related]
12. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
[TBL] [Abstract][Full Text] [Related]
13. Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.
Kierkels RGJ; Wopken K; Visser R; Korevaar EW; van der Schaaf A; Bijl HP; Langendijk JA
Radiother Oncol; 2016 Dec; 121(3):374-380. PubMed ID: 27614681
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
15. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
16. Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer treated without elective nodal irradiation.
Ahmed I; DeMarco M; Stevens CW; Fulp WJ; Dilling TJ
Med Dosim; 2011; 36(4):440-7. PubMed ID: 21397488
[TBL] [Abstract][Full Text] [Related]
17. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
18. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
19. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
20. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]